We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.3B
AUM Growth
+$580M
(+2.8%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
882
New
52
Increased
484
Reduced
289
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGD
New Gold Inc
NGD
|
+$52.1M |
| 2 |
Veeva Systems
VEEV
|
+$37.6M |
| 3 |
UnitedHealth
UNH
|
+$36.1M |
| 4 |
ServiceNow
NOW
|
+$35.9M |
| 5 |
B
Barrick Mining
B
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$43.4M |
| 2 |
ESV
Ensco Rowan plc
ESV
|
+$38.4M |
| 3 |
Walt Disney
DIS
|
+$35.1M |
| 4 |
McKesson
MCK
|
+$34.8M |
| 5 |
Hershey
HSY
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 56.36% |
| 2 | Technology | 9.22% |
| 3 | Energy | 7.08% |
| 4 | Healthcare | 5.95% |
| 5 | Financials | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CVS Health
CVS
$135B
| $9.28M | 0.04% |
147,102
-1,803
| -1% | -$107K |
|
227
Lowe's Companies
LOW
$121B
| $9.27M | 0.04% |
84,270
-942
| -1% | -$99.4K |
|
228
MidCap Financial Investment
MFIC
$801M
| $9.24M | 0.04% |
574,188
+6,124
| +1% | +$100K |
|
|
WTRU
229
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
| $9.13M | 0.04% |
150,693
+12,692
| +9% | +$742K |
|
230
Alnylam Pharmaceuticals
ALNY
$38.3B
| $8.93M | 0.04% |
111,041
+6,592
| +6% | +$522K |
|
231
TJX Companies
TJX
$179B
| $8.9M | 0.04% |
159,659
+3,365
| +2% | +$183K |
|
232
New Mountain Finance
NMFC
$654M
| $8.89M | 0.04% |
651,999
+70,547
| +12% | +$962K |
|
233
Welltower
WELL
$173B
| $8.88M | 0.04% |
97,936
+5,900
| +6% | +$513K |
|
234
Public Storage
PSA
$61.5B
| $8.85M | 0.04% |
36,067
+744
| +2% | +$187K |
|
235
Dow Inc
DOW
$22B
| $8.72M | 0.04% |
182,957
-6,636
| -4% | -$311K |
|
236
Invesco Mortgage Capital
IVR
$759M
| $8.67M | 0.04% |
56,617
+6,069
| +12% | +$963K |
|
|
MFA
237
MFA Financial
MFA
$932M
| $8.63M | 0.04% |
293,236
+8,017
| +3% | +$234K |
|
|
ARI
238
Apollo Commercial Real Estate
ARI
$864M
| $8.6M | 0.04% |
448,657
+13,804
| +3% | +$260K |
|
239
AGCO
AGCO
$8.41B
| $8.56M | 0.04% |
113,135
-596
| -0.5% | -$43.8K |
|
240
RPC Inc
RES
$1.13B
| $8.54M | 0.04% |
1,522,616
-733,848
| -33% | -$4.36M |
|
|
IFFT
241
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $8.48M | 0.04% |
180,177
+15,175
| +9% | +$741K |
|
|
LADR
242
Ladder Capital
LADR
$1.24B
| $8.45M | 0.04% |
489,501
+40,176
| +9% | +$680K |
|
|
GRFS
243
Grifois
GRFS
$5.55B
| $8.45M | 0.04% |
421,671
-17,704
| -4% | -$380K |
|
244
Ametek
AME
$53.9B
| $8.37M | 0.04% |
91,168
-10,181
| -10% | -$898K |
|
|
EMAG
245
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
| $8.29M | 0.04% |
385,000
| – | – |
|
|
PMT
246
PennyMac Mortgage Investment
PMT
$845M
| $8.14M | 0.04% |
366,258
+48,233
| +15% | +$1.06M |
|
247
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
| $8.12M | 0.04% |
343,332
+9,760
| +3% | +$230K |
|
248
New Oriental
EDU
$9.32B
| $8.07M | 0.04% |
+72,890
| New | +$7.63M |
|
249
Tesla
TSLA
$1.18T
| $8.02M | 0.04% |
499,575
-109,350
| -18% | -$1.71M |
|
250
Nuveen Municipal Credit Income Fund
NZF
$2.41B
| $8.02M | 0.04% |
493,939
+20,963
| +4% | +$338K |
|
Similar funds
DAM
VanEck Associates's Q3 2019 Portfolio in Review
As of Q3 2019, VanEck Associates held 882 positions worth $21.3B, up 2.8% from $20.8B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
VanEck Associates's Q3 2019 filing shows 52 new, 484 increased, 289 reduced and 51 closed positions. Its largest new stake was Veeva Systems: 234,351 shares worth $35.8M. The largest sale was Allergan plc, an estimated $43.4M.
By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 55% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2019 buy was Veeva Systems: 234,351 shares worth $35.8M.
- VanEck Associates added most to New Gold Inc in Q3 2019, an estimated $52.1M increase.
- VanEck Associates's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $43.4M.
- VanEck Associates fully exited Ensco Rowan plc in Q3 2019, selling an estimated $38.4M.
- VanEck Associates's ten largest holdings make up 36% of its $21.3B portfolio in Q3 2019.
- VanEck Associates opened 52 new positions and closed 51 in Q3 2019.
- VanEck Associates's portfolio value rose 2.8% quarter-over-quarter to $21.3B.
Based on VanEck Associates's 13F filing for Q3 2019, filed 8 Nov 2019.